发明申请
US20100273183A1 DIAGNOSTIC ASSAY FOR ANTI-VON WILLEBRAND FACTOR CLEAVING PROTEASE (ADAMTS13) ANTIBODIES
有权
用于抗血栓威因因子（ADAMTS13）抗体的诊断测定
- 专利标题： DIAGNOSTIC ASSAY FOR ANTI-VON WILLEBRAND FACTOR CLEAVING PROTEASE (ADAMTS13) ANTIBODIES
- 专利标题（中）： 用于抗血栓威因因子（ADAMTS13）抗体的诊断测定
-
申请号： US12829872申请日： 2010-07-02
-
公开(公告)号： US20100273183A1公开(公告)日： 2010-10-28
- 发明人: Friedrich Scheiflinger , Manfred Rieger , Barbara Plaimauer
- 申请人： Friedrich Scheiflinger , Manfred Rieger , Barbara Plaimauer
- 申请人地址： CH Glattpark (Opfikon) US IL Deerfield
- 专利权人： Baxter Healthcare S.A.,Baxter International, Inc.
- 当前专利权人： Baxter Healthcare S.A.,Baxter International, Inc.
- 当前专利权人地址： CH Glattpark (Opfikon) US IL Deerfield
- 主分类号： G01N33/53
- IPC分类号： G01N33/53
摘要：
This invention relates to a kit to be used in an assay system for determination of an anti-von Willebrand Factor-cleaving protease (“anti-vWF-cp”) antibody in a sample. The kit comprises vWF-cp and/or vWF-fragment(s) immobilized on a solid phase. The kit can be used in a method for determination of anti-vWF-cp antibodies from a patient, for the diagnosis of disorders associated with the occurrence of anti-vWF-cp-antibodies, and the differentiation of various forms of thrombotic microangiopathy.
公开/授权文献
信息查询
IPC分类:
